A vision of a world without polio: the OPV cessation strategy
- PMID: 16682224
- DOI: 10.1016/j.biologicals.2006.03.005
A vision of a world without polio: the OPV cessation strategy
Abstract
Once the eradication of wild poliovirus has been confirmed, the public health benefits of routine immunization with OPV will no longer outweigh the burden of disease either due to paralysis caused by OPV (vaccine associated paralytic polio), or by outbreaks caused by circulating vaccine-derived polioviruses. The eventual cessation of OPV use in routine immunization programmes worldwide will become necessary to assure a lasting eradication of polio. As the world moves towards polio eradication and its certification, preparations are therefore being intensified for OPV cessation, and the risk management framework for safe OPV cessation is being put in place. The framework includes bio-containment of all known poliovirus and potentially infected substances, development of an international stockpile of oral polio vaccine, ensuring a mechanism for continued global surveillance and response for polio after eradication has been certified, and national policies if countries decide to continue vaccinating with inactivated polio vaccine (IPV). It is ironic that the vaccine on which the world has depended for polio eradication will itself become a risk to eradication once the transmission of wild poliovirus has been interrupted. Final preparations for the eventual global and simultaneous cessation of OPV will require the same level of international cooperation and coordination that has brought the world to the verge of polio eradication.
Similar articles
-
Polio eradication: the OPV paradox.Rev Med Virol. 2003 Sep-Oct;13(5):277-91. doi: 10.1002/rmv.401. Rev Med Virol. 2003. PMID: 12931339 Review.
-
Risk management in a polio-free world.Risk Anal. 2006 Dec;26(6):1441-8. doi: 10.1111/j.1539-6924.2006.00840.x. Risk Anal. 2006. PMID: 17184391 Review.
-
Cost analysis of post-polio certification immunization policies.Bull World Health Organ. 2004 Jan;82(1):9-15. Epub 2004 Feb 26. Bull World Health Organ. 2004. PMID: 15106295 Free PMC article.
-
A developing country perspective on vaccine-associated paralytic poliomyelitis.Bull World Health Organ. 2004 Jan;82(1):53-7; discussion 57-8. Epub 2004 Feb 26. Bull World Health Organ. 2004. PMID: 15106301 Free PMC article.
-
Strengths and weaknesses of current polio vaccines--a view from industry.Dev Biol (Basel). 2001;105:61-6. Dev Biol (Basel). 2001. PMID: 11763338
Cited by
-
Polio elimination in Nigeria: A review.Hum Vaccin Immunother. 2016 Mar 3;12(3):658-63. doi: 10.1080/21645515.2015.1088617. Hum Vaccin Immunother. 2016. PMID: 26383769 Free PMC article. Review.
-
Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.Vaccine. 2015 Mar 3;33(10):1235-42. doi: 10.1016/j.vaccine.2015.01.018. Epub 2015 Jan 16. Vaccine. 2015. PMID: 25600519 Free PMC article. Review.
-
Estimating the likely coverage of inactivated poliovirus vaccine in routine immunization: evidence from demographic and health surveys.J Infect Dis. 2014 Nov 1;210 Suppl 1(Suppl 1):S465-74. doi: 10.1093/infdis/jiu343. J Infect Dis. 2014. PMID: 25316869 Free PMC article.
-
The problems with polio: toward eradication.Infect Dis Ther. 2013 Dec;2(2):167-74. doi: 10.1007/s40121-013-0014-6. Epub 2013 Sep 17. Infect Dis Ther. 2013. PMID: 25134479 Free PMC article.
-
Listening to the rumours: what the northern Nigeria polio vaccine boycott can tell us ten years on.Glob Public Health. 2013;8(10):1138-50. doi: 10.1080/17441692.2013.859720. Epub 2013 Dec 3. Glob Public Health. 2013. PMID: 24294986 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
